T21 - The latest data from 4,000+ patients

With over 4000 cannabis patients to date, treated for a broad variety of health conditions, Drug Science's longitudinal data allows exploration of key questions such as: which patients are benefitting the most from medical cannabis? How long lasting are results, and importantly, do the benefits continue to outweigh the risks? Join Dr Anne Schlag for a 30-minute session which digs in to the latest findings of T21, the UK's leading observational data registry on medical cannabis.